Enanta Pharmaceuticals reported $-33592000 in Net Income for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Abbvie ABBV:US $ 4490M 446M
Acorda Therapeutics ACOR:US $ -24.52M 3.96M
Amgen AMGN:US $ 1476M 423M
Anika Therapeutics ANIK:US $ -2.93M 2.86M
Arrowhead Research ARWR:US $ 44.37M 107.24M
AstraZeneca AZN:LN 386M 733M
Biocryst Pharmaceuticals BCRX:US $ -74.2M 56.42M
Biogen BIIB:US $ 303.8M 64.4M
Bristol Myers Squibb BMY:US $ 1278M 1094M
Clovis Oncology CLVS:US $ -60.17M 4.22M
Enanta Pharmaceuticals ENTA:US $ -33.59M 3.48M
Gilead Sciences GILD:US $ 19M 363M
GlaxoSmithKline GSK:LN 1802M 1053M
Halozyme Therapeutics HALO:US $ 60.11M 6.66M
Heron Therapeutics HRTX:US $ -63.89M 9.24M
Insmed INSM:US $ -94621000 18.36M
Intercept Pharmaceuticals ICPT:US $ -17.28M 19M
IONIS PHARMACEUT IONS:US $ -65.17M 289.78M
Johnson & Johnson JNJ:US $ 5149M 413M
Karyopharm Therapeutics KPTI:US $ -41399000 80.12M
Ligand Pharmaceuticals LGND:US $ -15.38M 9.97M
Marinus Pharmaceuticals MRNS:US $ -19.36M 8.94M
Merk MRK:US $ 4310M 552M
Neurocrine Biosciences NBIX:US $ 13.9M 21.2M
Novartis NOVN:VX SF 2222M 14086M
Novavax NVAX:US $ 203.41M 1049.69M
Pfizer PFE:US $ 7863M 4470M
Ptc Therapeutics PTCT:US $ -126.73M 16.54M
Sarepta Therapeutics SRPT:US $ -105.02M 16.96M
Vertex Pharmaceuticals VRTX:US $ 762.1M 8.01M
Vital Therapies VTL:US $ -20.81M 0.38M
YTE INCY:US $ 37.99M 525.86M